Skip to main content
. 2023 Mar 29. Online ahead of print. doi: 10.1016/bs.acc.2023.03.003

Table 2.

Commercial platforms and target genes for TB detection and drug resistance.

Method MTBC gene targets Rifampicin/isoniazid targets
RealTime MTB assay (Abbott) IS6110, pab rpoB, katG, inhA

FluoroType MTBDR assay (Hain Lifescience) rpoB rpoB, katG, inhA

Max MDR-TB (BD) IS6110, IS1081 rpoB, katG, inhA

Roche cobas MTB (Roche) 16sRNA, esxJ, esxK, esxM, esxP, esxW rpoB, katG, inhA

Xpert MTB/RIF (Cephied) rpoB rpoB

GenoType MTBDRplus (Hain Lifescience) rpoB, katG, inhA